Cholesterol | Page 40 of 55

Health :: Arkansas and Pfizer – New Partnership to Embrace Healthier Eating and Fitness

Governor Mike Huckabee of Arkansas and Pfizer Inc today announced the formation of Balance It Out: Arkansas, a new school-based community program to reduce the number of children who are overweight or at risk of becoming overweight, effectively diminishing their risk of developing chronic illness. In December 2006, the program will begin in Little Rock, AR, with a health fair for state employees designed to increase awareness of health risk factors and steps to prevent disease. Beginning in early 2007, the program will reach children and their families in the Dollarway (Pine Bluff), Harrison and Paragould school districts.

Erectile Dysfunction :: Levitra, vardenafil treated erectile dysfunction effectively

Clinical data demonstrated continued efficacy and tolerability of LEVITRA in men with ED and high blood pressure, diabetes and/or dyslipidemia, including high cholesterol. LEVITRA(R) (vardenafil HCl), is effective at first dose with continued success in treating erectile dysfunction (ED) in men with associated medical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. These data were presented today at the Sexual Medicine Society of North America (SMSNA) Fall meeting and published in the November issue of the International Journal of Clinical Practice.

Yoga :: Relax and refocus with yoga

The essence of optimal health is a healthy mind in a health body. Yoga, which has been practiced for more than 5,000 years, is a way to achieve both.

Vitamin :: Omega-3 fatty acids – Are the benefits just a fish tale?

The heart health benefits of omega-3 fatty acids — found in salmon, tuna and other cold-water fish — have long been touted. But according to the November issue of Mayo Clinic Women’s HealthSource, new research indicates that omega-3 fats might not be as beneficial as previously believed.

Obesity :: Salt intake is strongly associated with obesity

A study published in the journal “Progress in Cardiovascular Diseases” refutes the frequently repeated claims that a comprehensive salt reduction would not produce any overall health benefits, or would even increase diseases and shorten the life-span.

Cholesterol :: Pfizer’s torcetrapib/atorvastatin clinical trials – raising good cholesterol HDL

Pfizer Inc provided an update on the preliminary results of its torcetrapib/atorvastatin clinical trials in connection with the release of an American Heart Association abstract of a Phase 3 study in patients with heterozygous familial hypercholesterolemia (HeFH) that shows the drug significantly raising ‘good’ (HDL) cholesterol (56 percent) and additionally lowering ‘bad’ (LDL) cholesterol (27 percent) versus patients taking atorvastatin alone.

Ageing :: Calorie restriction – a prescription that extend life

The approach, called calorie restriction, involves eating about 30 percent fewer calories than normal while still getting adequate amounts of vitamins, minerals and other nutrients. Aside from direct genetic manipulation, calorie restriction is the only strategy known to extend life consistently in a variety of animal species, a report of study in a laboratory at the Wisconsin National Primate Research Center, highlighted by Michael Mason in the New York Times.

Cholesterol :: Patent Victory in Spanish Court Favoring Ranbaxy on Atorvastatin Unaffected

Ranbaxy Laboratories Limited said that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer’s EP 409 281) to be invalid for lack of novelty. The two rulings made on September 26, 2006, in Lek Pharmaceuticals v. Warner Lambert Co. and in Laboratorios Cinfa et al. v. Warner Lambert, found claims 1 to 3 of Pfizer to be invalid. These decisions came after considering the views of the Spanish Patent Office (SPO), in addition to technical expert reports.

Nutrition :: Cognis launches 3 natural, non-GMO health ingredients at SupplySide West

Traffic at the Cognis Nutrition & Health booth at the SupplySide West trade show is expected to be brisk as dietary supplement and functional food manufacturers discover the benefits of three new, non-GMO natural health ingredients Cognis is launching — Covi-ox? T-95 EU natural mixed tocopherols, Vegapure? F40 WDP E water dispersible natural plant sterols, Xangold? 20% natural lutein ester beadlets.

Diet :: Trans fatty acid contents to be declared on food labels – Australia

Trans fatty acid contents must be declared if a nutrition claim is made in respect of cholesterol or saturated, trans, polyunsaturated or monounsaturated fatty acids; or omega-3, omega-6 or omega-9 fatty acids. Some food manufacturers voluntarily list the amount of trans fatty acids in their products.